HUSSAIN IQBAL J

Chief Legal Officer sells 39,961 shares (40.0K) across 2 transactions for $1,004,917.61 in Centessa; post-sale holdings 117,645 shares, -25.4% reduction

HUSSAIN IQBAL J, Chief Legal Officer, executed 2 separate sales totaling 39,961 shares (40.0K shares) for $1,004,917.61 on 2026-01-30 and 2026-02-02 at blended average price $25.15, reducing his holdings from 157,606 shares to 117,645 shares. The -25.4% reduction in holdings is material. His prior 3 sells at CNTA have shown mixed timing outcomes: two sales in September 2025 saw substantial 90-day gains (+30.0% and +47.5%), while a December 2024 sale produced only +4.6% over 90 days—none were well-timed by the metric that measures whether the stock fell after the sale. The company remains unprofitable with $-54,891,000 net income in the latest period and zero revenue, characteristics relevant to context though not determinative of insider motivation. Current price of $25.48 reflects a +7.6% move in the prior 30 days but remains -14.8% from the 52-week high, placing these sales at a point where the stock had already recovered from earlier lows.

General Counsel Hussain Iqbal J sold 40,000 CNTA shares for $840,102 across 2 transactions; stock up 32.5% in 30 days and 83.1% in 90 days.

Hussain Iqbal J, General Counsel at Centessa Pharmaceuticals, executed 2 separate sales on 2025-09-09 and 2025-09-10, totaling 40,000 shares for $840,102.00 at a blended average price of $21.00, reducing his holdings from 145.4K to 105.4K shares (a -27.5% reduction). The stock has appreciated significantly since the transaction, rising 32.5% over 30 days and 83.1% over 90 days, now trading at $22.67 and near its 52-week high of $22.71. His prior sale at this ticker on 2024-12-16 yielded a 90-day return of +4.6%, indicating his last sellside transaction preceded a period of stock appreciation rather than decline. The company remains unprofitable with net income of $-50,343,000.00 and zero revenue in the latest quarter, though the stock's recent momentum contrasts sharply with its fundamental distress.

General Counsel Hussain Iqbal J sold 77,705 shares (38.2% reduction) at $16.39 amid unprofitable operations and near 52-week highs

General Counsel Hussain Iqbal J sold 77,705 shares at $16.39 on 2024-12-16, reducing his stake from 203,490 to 125,785 shares—a 38.2% reduction in holdings. The company reported a net loss of $42,566,000 for its most recent full fiscal year, indicating significant ongoing burn despite a market capitalization of $2,320,480,378. The sale occurred at a price only 5.7% below the 52-week high of $18.67 and follows a 30-day run of +10.0% and 90-day appreciation of +12.0%, placing the transaction at an elevated point in recent price momentum. The combination of substantial stake reduction by an executive officer, material operating losses, and execution near recent highs merits investor attention to underlying business trajectory and cash runway.